IBE

16.19

+0.25%↑

ENGI

18.935

+0.5%↑

ORA

13.4

+0.34%↑

RWE

32.61

-1.95%↓

IBE

16.19

+0.25%↑

ENGI

18.935

+0.5%↑

ORA

13.4

+0.34%↑

RWE

32.61

-1.95%↓

IBE

16.19

+0.25%↑

ENGI

18.935

+0.5%↑

ORA

13.4

+0.34%↑

RWE

32.61

-1.95%↓

IBE

16.19

+0.25%↑

ENGI

18.935

+0.5%↑

ORA

13.4

+0.34%↑

RWE

32.61

-1.95%↓

IBE

16.19

+0.25%↑

ENGI

18.935

+0.5%↑

ORA

13.4

+0.34%↑

RWE

32.61

-1.95%↓

Search

STRATEC Biomedical AG

Uždarymo kaina

27.15 -3.55

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

26.65

Max

28.4

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-2.9M

549K

Pardavimai

-11M

57M

P/E

Sektoriaus vid.

31.524

23.029

Dividendų pajamingumas

2.19

Pelno marža

0.959

Darbuotojai

1,462

EBITDA

-3.3M

7.1M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+33.8% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

2.19%

3.98%

Kitas uždarbis

2025-05-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

314M

Ankstesnė atidarymo kaina

30.7

Ankstesnė uždarymo kaina

27.15

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

STRATEC Biomedical AG Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-22 23:48; UTC

Karštos akcijos

Stocks to Watch: Deckers Outdoor, Intuit, Ross Stores, Lightbridge, NuScale Power, Centrus Energy

2025-05-22 23:07; UTC

Svarbiausios naujienos

Fortescue Energy CEO to Resign in Executive Overhaul

2025-05-22 23:03; UTC

Pagrindinės rinkos jėgos

Nuclear-Industry Stocks Get Boost After Report Says Trump Will Sign Orders to Jumpstart Field

2025-05-22 23:59; UTC

Rinkos pokalbiai

Gold Edges Higher, Supported by Lingering Worries Over U.S. Deficits -- Market Talk

2025-05-22 23:45; UTC

Rinkos pokalbiai

Nikkei May Trade in Range as Uncertainty Over Tariffs Continues -- Market Talk

2025-05-22 23:45; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-05-22 23:23; UTC

Rinkos pokalbiai

Global Energy Roundup: Market Talk

2025-05-22 23:23; UTC

Rinkos pokalbiai

Fortescue Iron Bridge Delay Disappoints; Executive Changes Welcomed -- Market Talk

2025-05-22 20:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-05-22 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-05-22 20:46; UTC

Įsigijimai, susijungimai, perėmimai

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

2025-05-22 20:39; UTC

Uždarbis

Tesla's Emissions Credits Are at Risk After Senate's California Vote -- Barrons.com

2025-05-22 20:36; UTC

Svarbiausios naujienos

Antitrust Cops Say BlackRock, Other Fund Giants May Have Harmed Energy Competition -- 4th Update

2025-05-22 20:36; UTC

Svarbiausios naujienos
Uždarbis

Workday Logs Higher 1Q Revenue, Backs Outlook; Initiates $1B Buyback Program

2025-05-22 20:32; UTC

Svarbiausios naujienos
Uždarbis

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

2025-05-22 20:27; UTC

Svarbiausios naujienos

Trump's 'Big, Beautiful Bill' Heads to Senate, Where New Fights Loom -- WSJ

2025-05-22 20:20; UTC

Svarbiausios naujienos

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

2025-05-22 20:17; UTC

Svarbiausios naujienos

The Deficit Is Unsettling Bond Traders. Here's How That Affects the Economy. -- 2nd Update

2025-05-22 20:16; UTC

Uždarbis

Intchains Group 1Q Rev $18.2M >ICG

2025-05-22 20:15; UTC

Svarbiausios naujienos

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

2025-05-22 20:08; UTC

Svarbiausios naujienos
Uždarbis

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

2025-05-22 20:05; UTC

Svarbiausios naujienos

Intuit Seeing Stable Environment for Consumers, Businesses While Tariffs Play Out

2025-05-22 20:04; UTC

Uždarbis

Workday Sees FY26 Subscription Revenue $8.8B >WDAY

2025-05-22 20:04; UTC

Uždarbis

Workday Sees 2Q Subscription Revenue $2.16B >WDAY

2025-05-22 20:01; UTC

Uždarbis

Intuit Sees FY25 EPS $13.19-EPS $12.24 >INTU

2025-05-22 20:01; UTC

Uždarbis

Workday 1Q Net $68M >WDAY

2025-05-22 20:01; UTC

Uždarbis

Workday 1Q EPS 25c >WDAY

2025-05-22 20:01; UTC

Uždarbis

Workday 1Q Adj EPS $2.23 >WDAY

2025-05-22 20:01; UTC

Uždarbis

Workday 1Q Subscription Revenue $2.06B >WDAY

2025-05-22 20:01; UTC

Uždarbis

Workday 1Q Rev $2.24B >WDAY

Akcijų palyginimas

Kainos pokytis

STRATEC Biomedical AG Prognozė

Kainos tikslas

By TipRanks

33.8% į viršų

12 mėnesių prognozė

Vidutinis 38 EUR  33.8%

Aukščiausias 41 EUR

Žemiausias 33 EUR

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines STRATEC Biomedical AG kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

3 ratings

1

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

N/A / 24.5Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

No Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.